Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$8.02 - $8.67 $5.22 Million - $5.65 Million
-651,154 Reduced 85.73%
108,410 $920,000
Q4 2023

Feb 13, 2024

BUY
$7.78 - $8.62 $389,000 - $430,999
50,000 Added 7.05%
759,564 $6.25 Million
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $1.5 Million - $1.71 Million
190,836 Added 36.79%
709,564 $5.91 Million
Q2 2023

Aug 11, 2023

SELL
$8.04 - $9.0 $24,119 - $27,000
-3,000 Reduced 0.58%
518,728 $4.35 Million
Q1 2023

May 15, 2023

BUY
$7.57 - $8.37 $542,859 - $600,229
71,712 Added 15.94%
521,728 $4.25 Million
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $2.53 Million - $3.38 Million
450,016 New
450,016 $2.74 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $48.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Qvidtvm Management LLC Portfolio

Follow Qvidtvm Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvidtvm Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qvidtvm Management LLC with notifications on news.